Skip to content
10-Q

Quarterly Report

FluoroPharma Medical, Inc.

0001654954-16-003944

← back to feed
Filed
Nov 14, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 14, 2016 34.07M sh
Operating Cash Flow Q3 2016 · Sep 30, 2016 −$763.88K
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$1.71M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $27.5K
Cash And Equivalents Q3 2016 · Dec 31, 2015 $290.85K
Cash And Equivalents Q3 2016 · Sep 30, 2015 $1.3M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $252.15K
Stockholders Equity Q3 2016 · Sep 30, 2016 −$9.93M
Stockholders Equity Q3 2016 · Dec 31, 2015 −$7.86M
Current Liabilities Q3 2016 · Sep 30, 2016 $10.32M
Current Liabilities Q3 2016 · Dec 31, 2015 $8.7M
Current Assets Q3 2016 · Sep 30, 2016 $89.41K
Current Assets Q3 2016 · Dec 31, 2015 $509K
Total Assets Q3 2016 · Sep 30, 2016 $387.27K
Total Assets Q3 2016 · Dec 31, 2015 $838.6K
Eps Diluted Q3 2016 · Sep 30, 2016 $0.00
Eps Diluted Q3 2016 · Sep 30, 2016 −$0.07
Eps Diluted Q3 2016 · Sep 30, 2015 −$0.08
Eps Diluted Q3 2016 · Jun 30, 2015 $0.00
Eps Basic Q3 2016 · Sep 30, 2016 $0.01
Eps Basic Q3 2016 · Sep 30, 2016 −$0.07
Eps Basic Q3 2016 · Sep 30, 2015 −$0.08
Eps Basic Q3 2016 · Jun 30, 2015 $0.00
Sga Expense Q3 2016 · Sep 30, 2016 $341.46K
Sga Expense Q3 2016 · Sep 30, 2016 $1.27M
Sga Expense Q3 2016 · Sep 30, 2015 $1.77M
Sga Expense Q3 2016 · Jun 30, 2015 $492.97K
Rd Expense Q3 2016 · Sep 30, 2016 −$21.84K
Rd Expense Q3 2016 · Sep 30, 2016 $407.49K
Rd Expense Q3 2016 · Sep 30, 2015 $576.82K
Rd Expense Q3 2016 · Jun 30, 2015 $291.62K
Net Income Q3 2016 · Sep 30, 2016 $384.11K
Net Income Q3 2016 · Sep 30, 2016 −$1.92M
Net Income Q3 2016 · Sep 30, 2015 −$1.9M
Net Income Q3 2016 · Jun 30, 2015 $104.91K
Operating Income Q3 2016 · Sep 30, 2016 −$319.62K
Operating Income Q3 2016 · Sep 30, 2016 −$1.68M
Operating Income Q3 2016 · Sep 30, 2015 −$2.35M
Operating Income Q3 2016 · Jun 30, 2015 −$784.59K